| Product Code: ETC7407004 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Guyana`s antiparasitic import market in 2024 continues to be dominated by top exporters including India, Bangladesh, Canada, and the USA. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, with significant growth reflected in the impressive Compound Annual Growth Rate (CAGR) of 53.34% from 2020 to 2024. The exceptional growth rate of 174.66% from 2023 to 2024 suggests a rapidly expanding market, presenting lucrative opportunities for stakeholders in the antiparasitic industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Guyana Antiparasitic Market Overview |
3.1 Guyana Country Macro Economic Indicators |
3.2 Guyana Antiparasitic Market Revenues & Volume, 2021 & 2031F |
3.3 Guyana Antiparasitic Market - Industry Life Cycle |
3.4 Guyana Antiparasitic Market - Porter's Five Forces |
3.5 Guyana Antiparasitic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Guyana Antiparasitic Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Guyana Antiparasitic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Guyana Antiparasitic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of parasitic infections in Guyana |
4.2.2 Growing awareness about the importance of antiparasitic treatments |
4.2.3 Government initiatives to improve healthcare infrastructure and access to medications |
4.3 Market Restraints |
4.3.1 Limited availability of advanced antiparasitic medications in Guyana |
4.3.2 High cost of antiparasitic treatments for the general population |
4.3.3 Lack of skilled healthcare professionals for proper diagnosis and treatment of parasitic infections |
5 Guyana Antiparasitic Market Trends |
6 Guyana Antiparasitic Market, By Types |
6.1 Guyana Antiparasitic Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Guyana Antiparasitic Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Guyana Antiparasitic Market Revenues & Volume, By Anthelmintics, 2021- 2031F |
6.1.4 Guyana Antiparasitic Market Revenues & Volume, By Antiprotozoals, 2021- 2031F |
6.1.5 Guyana Antiparasitic Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Guyana Antiparasitic Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Guyana Antiparasitic Market Revenues & Volume, By Giardiasis, 2021- 2031F |
6.2.3 Guyana Antiparasitic Market Revenues & Volume, By Trichuriasis, 2021- 2031F |
6.2.4 Guyana Antiparasitic Market Revenues & Volume, By Filariasis, 2021- 2031F |
6.2.5 Guyana Antiparasitic Market Revenues & Volume, By Neurocysticercosis, 2021- 2031F |
6.2.6 Guyana Antiparasitic Market Revenues & Volume, By Hydatid disease, 2021- 2031F |
6.2.7 Guyana Antiparasitic Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Guyana Antiparasitic Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Guyana Antiparasitic Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F |
6.3.3 Guyana Antiparasitic Market Revenues & Volume, By Retail pharmacies, 2021- 2031F |
6.3.4 Guyana Antiparasitic Market Revenues & Volume, By Online pharmacies, 2021- 2031F |
6.3.5 Guyana Antiparasitic Market Revenues & Volume, By Others, 2021- 2031F |
7 Guyana Antiparasitic Market Import-Export Trade Statistics |
7.1 Guyana Antiparasitic Market Export to Major Countries |
7.2 Guyana Antiparasitic Market Imports from Major Countries |
8 Guyana Antiparasitic Market Key Performance Indicators |
8.1 Percentage increase in the number of healthcare facilities offering antiparasitic treatments |
8.2 Number of educational campaigns conducted to raise awareness about parasitic infections and treatments |
8.3 Average waiting time for patients to receive antiparasitic medications at healthcare facilities |
9 Guyana Antiparasitic Market - Opportunity Assessment |
9.1 Guyana Antiparasitic Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Guyana Antiparasitic Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Guyana Antiparasitic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Guyana Antiparasitic Market - Competitive Landscape |
10.1 Guyana Antiparasitic Market Revenue Share, By Companies, 2024 |
10.2 Guyana Antiparasitic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here